FluGen Awarded $11.4M Grant
FluGen has been awarded an $11.4 million grant from the United States Department of Defense to conduct a safety and immunogenicity study of the influenza vaccine (M2SR, the company announced…
FluGen has been awarded an $11.4 million grant from the United States Department of Defense to conduct a safety and immunogenicity study of the influenza vaccine (M2SR, the company announced…
Nimble Therapeutics and RayzeBio, a biotech company focused on improving outcomes for people with cancer, have entered a strategic collaboration, the company announced recently. According to a release, the purpose…
SHINE Medical Technologies has completed a $150 million Series C-5 financing round led by Koch Disruptive Technologies (KDT), with participation from Fidelity Management & Research Company, Baillie Gifford and other…
SHINE Medical Technologies will build its European medical isotope production facility in the Netherlands, the company announced today. According to a release, the European facility, which will be located in…
NorthStar Medical Radioisotopes has received two custom-built IBA Rhodotron TT 300-HE electron beam accelerators at its facility, the company announced recently. According to a release, the accelerators are critical components…
OnLume Surgical announced recently that it has closed a $7 million Series A financing round. “The completion of the Series A financing, plus the Phase II grant from NCI, provides the…
HealthMyne’s technology as a radiomics tool to inform clinical decision-making, identify imaging biomarkers and predict tumor response to cancer treatment was validated by Cancer Control, the company announced recently. “By extracting…
SHINE Medical Technologies and Phoenix have completed a merger under which Phoenix has become a wholly owned subsidiary of SHINE, the companies announced today. “SHINE and Phoenix have shared a…
Promega has opened the Kornberg Center, its newly constructed research and development facility, the company announced today. According to a release, the three-story, 280,000-square-foot building will support core product and technology…
Stem Pharm has been awarded a $1.7 million SBIR grant from the National Institute of Environmental Health Sciences of the National Institutes of Health (NIH), the company announced recently. According…